Importance In recurrent human papilloma virus (HPV)–driven cancer, immune checkpoint
blockade with anti–programmed cell death 1 (PD-1) antibodies produces tumor regression in …

Background In a pilot study involving patients with cutaneous squamous-cell carcinoma, a
high percentage of patients had a pathological complete response with the use of two doses …

Purpose Adenoid cystic carcinomas (ACCs) represent a heterogeneous group of
chemotherapy refractory tumors, with a subset demonstrating an aggressive phenotype. We …

Background Anaplastic thyroid carcinoma (ATC) is a rare but deadly form of thyroid cancer.
Kinase inhibitors kinase inhibitors have shown clinical efficacy in the management of ATC, …

We present a proteogenomic study of 108 human papilloma virus (HPV)-negative head and
neck squamous cell carcinomas (HNSCCs). Proteomic analysis systematically catalogs …

Importance Anaplastic thyroid carcinoma (ATC) historically has a 4-month median overall
survival (OS) from time of diagnosis, with disease-specific mortality approaching 100%. The …

Background: Anaplastic thyroid cancer (ATC) is one of the most lethal forms of cancer with a
high mortality rate. Current guidelines support surgery for resectable ATC followed by …

Background Despite some successes with checkpoint inhibitors for treating cancer, most
patients remain refractory to treatment, possibly due to the inhibitory nature of the tumor stroma …

Background: When achieved, complete surgical resection improves outcomes in anaplastic
thyroid carcinoma (ATC). However, most ATC patients present with advanced inoperable …

Background Patients with advanced rare cancers have poor prognosis and few treatment
options. As immunotherapy is effective across multiple cancer types, we aimed to assess …